Biocryst Pharmaceuticals reported $27.53M in Stock for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Alnylam Pharmaceuticals ALNY:US USD 128.96M 13.47M
Biocryst Pharmaceuticals BCRX:US USD 27.53M 514K
Chugai Pharma 4519:JP JPY 292.21B 20.81B
Daiichi Sankyo 4568:JP JPY 266.68B 4.56B
Gilead Sciences GILD:US USD 2.82B 218M
GlaxoSmithKline GSK:LN GBP 5.15B 487M
Intra Cellular Therapies ITCI:US USD 23.92M 323K
Novavax NVAX:US USD 36.68M 45.75M
Ptc Therapeutics PTCT:US USD 21.81M 7M
Regeneron Pharmaceuticals REGN:US USD 2.4B 10.3M
Roche Holding ROG:VX 8.6B 313M
Sarepta Therapeutics SRPT:US USD 203.97M 17.22M
Ultragenyx Pharmaceutical RARE:US USD 26.77M 4.92M
Vertex Pharmaceuticals VRTX:US USD 460.6M 72.4M
YTE INCY:US USD 120.96M 75.09M